Status:
COMPLETED
Ventilator-Associated Pneumonia in Critically Ill COVID-19 vs. Non-COVID-19 Patients
Lead Sponsor:
University of Turin, Italy
Conditions:
Infections
Critical Illness
Eligibility:
All Genders
18+ years
Brief Summary
The COVID-19 pandemic has led to an increased incidence of ventilator-associated pneumonia (VAP) among critically ill patients. However, in a context of high prevalence of multidrug-resistant organism...
Detailed Description
The study aims to explore the occurrence and characteristics of ventilator-associated pneumonia (VAP) in critically ill patients during two distinct periods: the pre-pandemic era and the COVID-19 pand...
Eligibility Criteria
Inclusion
- All adult patients diagnosed with ventilator-associated pneumonia
- Patients admitted to the intensive care units
- Patients who underwent mechanical ventilation for a duration longer than 48 hours
Exclusion
- Patients in extreme end-of-life conditions
- Pregnant individuals
- Patients under 18 years of age
- Patients who did not meet the diagnosis criteria for ventilator-associated pneumonia
- Patients who underwent mechanical ventilation for a duration equal to or shorter than 48 hours
- Ventilator-associated tracheobronchitis
Key Trial Info
Start Date :
January 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2022
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT05972980
Start Date
January 1 2016
End Date
December 31 2022
Last Update
August 2 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
AOU Città della Salute e della Scienza di Torino
Torino, Italy, 10100